<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04160832</url>
  </required_header>
  <id_info>
    <org_study_id>18-2827</org_study_id>
    <nct_id>NCT04160832</nct_id>
  </id_info>
  <brief_title>Prevalence and Spectrum of Cancer Susceptibility Among Patients With Advanced Colorectal Polyps</brief_title>
  <official_title>Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Advanced Colorectal Polyps</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is being conducted to determine the prevalence and risk factors for germline cancer
      susceptibility genetic mutations among patients with advanced colorectal polyps.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 24, 2019</start_date>
  <completion_date type="Anticipated">October 2023</completion_date>
  <primary_completion_date type="Anticipated">October 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of germline cancer predisposition gene mutations in patients with advanced colorectal polyps</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Risk factors for genetic mutations in patients with advanced colorectal polyps</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">450</enrollment>
  <condition>Colorectal Neoplasm</condition>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Multi-Cancer Cancer Panel</intervention_name>
    <description>Eligible patients will receive genetic testing to determine germline cancer predisposition.</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      1. Polyp tissue

        2. Blood sample

        3. Saliva
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Males and females aged 18 - 89, who have been diagnosed with advanced colorectal polyps.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Provision to sign and date the consent form

          -  Stated willingness to comply with all study procedures and be available for the
             duration of the study

          -  Be a male or female aged 18-89

          -  Undergone colonoscopy

          -  At least one advanced colorectal polyp, defined as having any of the following:

          -  Any polyp â‰¥ 1cm (adenoma or serrated polyp)

          -  Any polyp with villous architecture

          -  Any polyp with high-grade dysplasia

          -  Sessile serrated polyps with any dysplasia

          -  Traditional serrated adenoma

        Exclusion Criteria:

          -  Known hereditary cancer syndrome

          -  Personal history of inflammatory bowel disease

          -  Personal history of colorectal cancer

          -  Polyp histology or size unavailable or not documented
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jeannine Espinoza, BA</last_name>
    <phone>303-724-4466</phone>
    <email>jeannine.espinoza@cuanschutz.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Colorado Denver</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeannine M Espinoza</last_name>
      <phone>303-724-4466</phone>
      <email>jeannine.espinoza@ucdenver.edu</email>
    </contact>
    <investigator>
      <last_name>Swati G Patel, MD MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 8, 2019</study_first_submitted>
  <study_first_submitted_qc>November 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2019</study_first_posted>
  <last_update_submitted>November 8, 2019</last_update_submitted>
  <last_update_submitted_qc>November 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Colorado, Denver</investigator_affiliation>
    <investigator_full_name>Swati Patel</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>genetics</keyword>
  <keyword>polyps</keyword>
  <keyword>cancer</keyword>
  <keyword>multi-gene panel</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

